Cramer Rosenthal McGlynn’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-154,591
| Closed | -$12.2M | – | 139 |
|
|
2018
Q3 | $12.2M | Sell |
154,591
-280,048
| -64% | -$22.2M | 0.23% | 109 |
|
|
2018
Q2 | $31.8M | Sell |
434,639
-361,855
| -45% | -$26.5M | 0.57% | 72 |
|
|
2018
Q1 | $50.4M | Sell |
796,494
-224,275
| -22% | -$14.2M | 0.82% | 54 |
|
|
2017
Q4 | $52M | Sell |
1,020,769
-4,515
| -0.4% | -$230K | 0.84% | 50 |
|
|
2017
Q3 | $53.8M | Sell |
1,025,284
-42,560
| -4% | -$2.23M | 0.86% | 42 |
|
|
2017
Q2 | $54.4M | Buy |
1,067,844
+75,055
| +8% | +$3.82M | 0.83% | 48 |
|
|
2017
Q1 | $44.1M | Sell |
992,789
-26,905
| -3% | -$1.19M | 0.67% | 67 |
|
|
2016
Q4 | $45M | Sell |
1,019,694
-72,280
| -7% | -$3.19M | 0.67% | 68 |
|
|
2016
Q3 | $43.7M | Buy |
1,091,974
+24,984
| +2% | +$1M | 0.67% | 66 |
|
|
2016
Q2 | $50.9M | Sell |
1,066,990
-13,450
| -1% | -$642K | 0.82% | 39 |
|
|
2016
Q1 | $45.3M | Buy |
1,080,440
+16,710
| +2% | +$701K | 0.71% | 62 |
|
|
2015
Q4 | $46.9M | Buy |
1,063,730
+76,953
| +8% | +$3.39M | 0.7% | 60 |
|
|
2015
Q3 | $47.1M | Sell |
986,777
-4,412
| -0.4% | -$211K | 0.64% | 61 |
|
|
2015
Q2 | $57.8M | Sell |
991,189
-51,525
| -5% | -$3M | 0.71% | 53 |
|
|
2015
Q1 | $52.6M | Sell |
1,042,714
-65,825
| -6% | -$3.32M | 0.59% | 71 |
|
|
2014
Q4 | $49.8M | Buy |
1,108,539
+149,632
| +16% | +$6.73M | 0.51% | 79 |
|
|
2014
Q3 | $35.3M | Sell |
958,907
-118,237
| -11% | -$4.36M | 0.35% | 98 |
|
|
2014
Q2 | $47.6M | Sell |
1,077,144
-161,884
| -13% | -$7.15M | 0.38% | 97 |
|
|
2014
Q1 | $53.8M | Sell |
1,239,028
-26,274
| -2% | -$1.14M | 0.41% | 95 |
|
|
2013
Q4 | $53.8M | Buy |
1,265,302
+115,013
| +10% | +$4.89M | 0.38% | 94 |
|
|
2013
Q3 | $39.1M | Sell |
1,150,289
-104,425
| -8% | -$3.55M | 0.29% | 112 |
|
|
2013
Q2 | $39.2M | Buy |
+1,254,714
| New | +$39.2M | 0.3% | 115 |
|